Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
GDOC vs ETHSX
Shared holdings
15
GDOC covered by ETHSX
47.32%
ETHSX covered by GDOC
47.32%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 40 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
GDOC (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 12.20% | |
| JOHNSON&JOHNSON | 8.10% | |
| ASTRAZENECA PLC | 6.41% | |
| MERCK & CO | 5.99% | |
| BOSTON SCIENTIFIC CORP | 5.81% | |
| THERMO FISHER SCIENTIFIC INC | 4.62% | |
| INTUITIVE SURGICAL INC | 4.47% | |
| GUARDANT HEALTH INC | 3.73% | |
| HOYA CORP | 3.63% | |
| ARGENX SE SPONSORED ADR | 3.60% | |
| CENCORA INC | 3.39% | |
| ABBOTT LABS | 3.13% | |
| LONZA GROUP -REG | 2.94% | |
| AGILENT TECHNOLOGIES INC | 2.91% | |
| DEXCOM INC | 2.68% | |
| ROIVANT SCIENCES LTD | 2.23% | |
| METTLER-TOLEDO INTL INC | 1.77% | |
| APOGEE THERAPEUTICS INC | 1.62% | |
| Sartorius Stedim Biotech S.A. | 1.59% | |
| IONIS PHARMACEUTICALS INC | 1.41% | |
| QIAGEN NV | 1.39% | |
| REPLIGEN CORP | 1.26% | |
| INSMED INC | 1.22% | |
| PENUMBRA INC | 1.14% | |
| Goldman Sachs Treasury Obligations Fund Institutional Class | 1.09% | |
| NATERA INC | 1.05% | |
| XENON PHARMACEUTICALS INC | 1.03% | |
| ROYALTY PHARMA PLC | 1.01% | |
| UNITEDHEALTH GRP | 1.01% | |
| CYTOKINETICS INC | 0.98% | |
| BRIDGEBIO PHARMA INC | 0.92% | |
| MADRIGAL PHARMACEUTICALS INC | 0.89% | |
| RHYTHM PHARMACEUTICALS INC | 0.88% | |
| CG ONCOLOGY INC | 0.83% | |
| ARCELLX INC | 0.82% | |
| GENEDX HOLDINGS CORP-A | 0.59% | |
| REVOLUTION MEDICINES INC | 0.52% | |
| INSULET CORP | 0.47% | |
| ULTRAGENYX PHARMA INC | 0.37% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.30% |
ETHSX (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 11.36% | |
| ABBVIE INC | 6.68% | |
| ASTRAZENECA PLC | 6.56% | |
| JOHNSON&JOHNSON | 6.30% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 5.87% | |
| MERCK & CO | 4.45% | |
| BRISTOL-MYERS SQUIBB CO | 4.11% | |
| UNITEDHEALTH GRP | 3.75% | |
| VERTEX PHARMACEUTICALS INC | 3.52% | |
| GILEAD SCIENCES INC | 3.28% | |
| ABBOTT LABS | 3.22% | |
| ZOETIS INC CL A | 3.07% | |
| Sanofi SA | 2.91% | |
| THERMO FISHER SCIENTIFIC INC | 2.87% | |
| INTUITIVE SURGICAL INC | 2.85% | |
| BOSTON SCIENTIFIC CORP | 2.64% | |
| STRYKER CORP | 2.49% | |
| MEDTRONIC PLC | 2.11% | |
| LONZA GROUP -REG | 1.79% | |
| CSL LTD COMMON STOCK | 1.64% | |
| ARGENX SE SPONSORED ADR | 1.57% | |
| EDWARDS LIFESCIENCES CORP | 1.48% | |
| METTLER-TOLEDO INTL INC | 1.39% | |
| Novartis AG (Registered) | 1.38% | |
| COOPER COS INC | 1.25% | |
| NOVO NORDISK-B | 1.25% | |
| STRAUMANN HOLDG AG (REGD) | 1.18% | |
| ROYALTY PHARMA PLC | 1.16% | |
| DANAHER CORP | 0.91% | |
| NEUROCRINE BIOSCIENCES INC | 0.80% | |
| MCKESSON CORP | 0.73% | |
| BIO-TECHNE CORP | 0.69% | |
| OPTION CARE HEALTH INC | 0.68% | |
| RECORDATI SPA | 0.61% | |
| HEARTFLOW INC | 0.59% | |
| GENMAB AS | 0.57% | |
| AMPLIFON SPA | 0.41% | |
| NEWAMSTERDAM PHARMA COMPANY NV | 0.34% | |
| ESSILORLUXOTTICA | 0.33% | |
| CARIS LIFE SCIENCES INC | 0.32% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 0.29% | |
| APOGEE THERAPEUTICS INC | 0.28% | |
| XENON PHARMACEUTICALS INC | 0.26% | |
| MSILF-GOVT-INS | 0.03% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.